image
Healthcare - Biotechnology - NASDAQ - US
$ 0.3208
-11.5 %
$ 62.2 M
Market Cap
-0.15
P/E
BALANCE SHEET
619 M ASSETS
11.58%
425 M LIABILITIES
18.43%
195 M EQUITY
-0.92%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition bluebird bio, Inc.
image
Current Assets 282 M
Cash & Short-Term Investments 222 M
Receivables 13 M
Other Current Assets 46.9 M
Non-Current Assets 337 M
Long-Term Investments 0
PP&E 267 M
Other Non-Current Assets 70.4 M
Current Liabilities 200 M
Accounts Payable 18.5 M
Short-Term Debt 106 M
Other Current Liabilities 75.7 M
Non-Current Liabilities 225 M
Long-Term Debt 224 M
Other Non-Current Liabilities 92 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 221.8 113.0 161.2 317.7 327.2 402.6 758.5 278.9 164.3 347.8 206.3 67.0 25.6
Short Term Investments 8.9 67.3 138.3 833.5 779.2 982.7 531.6 425.5 353.7 125.7 0 0 3.5
Receivables 13.0 10.8 11.4 2.4 12.8 0 8.4 0 0 0 0 0 0
Inventory 22.9 (1.4) (108.5) (149.7) (144.3) (506.1) (11.5) 0 0 0 0 0 0
Other Current Assets 24.0 8.6 25.6 522.2 32.9 19.8 21.2 28.0 12.0 12.9 10.7 1.5 0.9
Total Current Assets 281.7 199.5 336.5 1 215.5 1 152.2 1 419.0 1 614.3 724.2 524.0 480.0 212.0 67.8 30.0
PP&E 267.0 291.4 101.2 346.9 337.1 246.6 199.6 157.0 82.6 15.7 10.9 1.3 0.7
Intangible Assets 10.4 4.9 0 10.0 14.3 13.2 16.9 20.7 24.5 28.2 0 0 0
Goodwill 5.6 5.6 5.6 13.1 13.1 13.1 13.1 13.1 13.1 13.1 0 0 0
Long Term Investments 0 1.4 97.1 122.9 131.5 506.1 324.2 180.5 347.8 18.4 0 0 0
Other Long Term Assets 54.3 52.1 53.3 72.8 79.2 44.8 23.9 22.7 10.4 (0.7) 0.8 0.2 0.2
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 619.2 554.9 593.8 1 781.3 1 727.4 2 242.8 1 900.6 1 118.1 1 002.3 556.7 224.4 69.3 30.9
LIABILITIES
Accounts Payable 18.5 14.9 25.9 13.8 43.0 17.8 12.9 13.7 6.3 3.0 4.4 2.2 1.8
Short Term Debt 105.9 88.2 46.3 9.7 40.4 1.4 1.1 0 0 0 0 0 0
Other Current Liabilities 75.7 52.0 78.5 180.1 131.8 127.2 56.0 54.7 28.1 14.6 5.2 2.1 0.8
Total Current Liabilities 200.1 128.2 153.0 203.6 223.6 146.4 95.6 74.5 40.4 43.0 34.9 4.6 2.9
Long Term Debt 224.4 278.8 66.4 55.7 170.8 153.3 154.7 120.1 61.9 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 2.7 10.4 8.3 1.9 0.7 0 0
Other Liabilities 92 K 92 K 93 K 141.1 38.2 41.7 5.0 13.8 13.6 15.3 6.9 120.1 83.1
Total Liabilities 424.6 358.6 219.5 426.2 442.4 357.8 277.1 248.7 151.8 65.5 72.7 125.1 86.6
EQUITY
Common Stock 1.9 0.8 0.7 0.7 0.6 0.5 0.5 0.4 0.4 0.3 0.2 3 K 2 K
Retained Earnings (4 260.3) (3 986.5) (3 719.9) (2 900.5) (2 281.9) (1 498.8) (913.8) (577.7) (314.2) (147.4) (98.7) (73.4) (63.4)
Other Accumulative Comprehensive Income/Loss (1.8) (4.1) (2.9) (5.5) (1.9) (3.6) (4.2) (1.1) (2.3) 71 K (1.5) 0 1 K
Total Equity 194.5 196.3 374.3 1 355.1 1 285.0 1 885.1 1 623.4 869.4 850.5 491.3 151.7 (55.7) (55.7)
Total Liabilities and Equity 619.2 554.9 593.8 1 781.3 1 727.4 2 242.8 1 900.6 1 118.1 1 002.3 556.7 224.4 69.3 30.9
SHARES OUTSTANDING
Common Shares Outstanding 109.8 78.6 68.9 62.2 55.2 52.0 43.5 37.3 34.7 26.5 12.6 22.8 22.8